201 related articles for article (PubMed ID: 32593420)
1. Are β-lactam concentrations adequate in severe sepsis and septic shock in children?
Chosidow A; Benaboud S; Beranger A; Zheng Y; Moulin F; Dupic L; Renolleau S; Treluyer JM; Oualha M
Therapie; 2020; 75(6):633-640. PubMed ID: 32593420
[TBL] [Abstract][Full Text] [Related]
2. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Hites M; Taccone FS; Wolff F; Cotton F; Beumier M; De Backer D; Roisin S; Lorent S; Surin R; Seyler L; Vincent JL; Jacobs F
Antimicrob Agents Chemother; 2013 Feb; 57(2):708-15. PubMed ID: 23147743
[TBL] [Abstract][Full Text] [Related]
4. Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.
Ulldemolins M; Vaquer S; Llauradó-Serra M; Pontes C; Calvo G; Soy D; Martín-Loeches I
Crit Care; 2014 Jun; 18(3):227. PubMed ID: 25042938
[TBL] [Abstract][Full Text] [Related]
5. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
Kaska M; Havel E; Selke-Krulichova I; Safranek P; Bezouska J; Martinkova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):219-226. PubMed ID: 29582860
[TBL] [Abstract][Full Text] [Related]
6. Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis.
Hartman SJF; Boeddha NP; Ekinci E; Koch BCP; Donders R; Hazelzet JA; Driessen GJ; de Wildt SN
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1255-1260. PubMed ID: 30968258
[TBL] [Abstract][Full Text] [Related]
7. β-lactam dosing at the early phase of sepsis: Performance of a pragmatic protocol for target concentration achievement in a prospective cohort study.
Winiszewski H; Despres C; Puyraveau M; Lagoutte-Renosi J; Montange D; Besch G; Floury SP; Chaignat C; Labro G; Vettoretti L; Clairet AL; Capellier G; Vivet B; Piton G
J Crit Care; 2022 Feb; 67():141-146. PubMed ID: 34768176
[TBL] [Abstract][Full Text] [Related]
8. Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.
Lheureux O; Trepo E; Hites M; Cotton F; Wolff F; Surin R; Creteur J; Vincent JL; Gustot T; Jacobs F; Taccone FS
Liver Int; 2016 Jul; 36(7):1002-10. PubMed ID: 26645828
[TBL] [Abstract][Full Text] [Related]
9. Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance.
Teshome BF; Vouri SM; Hampton N; Kollef MH; Micek ST
Pharmacotherapy; 2019 Mar; 39(3):261-270. PubMed ID: 30506852
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?
Marsot A
J Pharm Pharm Sci; 2020; 23():470-485. PubMed ID: 33227230
[TBL] [Abstract][Full Text] [Related]
11. What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling.
Delattre IK; Hites M; Laterre PF; Dugernier T; Spapen H; Wallemacq PE; Jacobs F; Taccone FS
Int J Antimicrob Agents; 2020 Oct; 56(4):106113. PubMed ID: 32721604
[TBL] [Abstract][Full Text] [Related]
12. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
Seyler L; Cotton F; Taccone FS; De Backer D; Macours P; Vincent JL; Jacobs F
Crit Care; 2011; 15(3):R137. PubMed ID: 21649882
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactam exposure and safety in intermittent or continuous infusion in critically ill children: an observational monocenter study.
Debray A; Callot D; Hirt D; Bille E; Renolleau S; Chouchana L; Tréluyer JM; Oualha M; Béranger A
Eur J Pediatr; 2023 Mar; 182(3):965-973. PubMed ID: 36422708
[TBL] [Abstract][Full Text] [Related]
14. β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance.
Jacobs A; Taccone FS; Roberts JA; Jacobs F; Cotton F; Wolff F; Creteur J; Vincent JL; Hites M
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987138
[TBL] [Abstract][Full Text] [Related]
15. Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome.
Van Der Heggen T; Dhont E; Willems J; Herck I; Delanghe JR; Stove V; Verstraete AG; Vanhaesebrouck S; De Paepe P; De Cock PAJG
Pediatr Crit Care Med; 2022 Jul; 23(7):e309-e318. PubMed ID: 35426861
[TBL] [Abstract][Full Text] [Related]
16. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.
Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM
Crit Care Resusc; 2019 Mar; 21(1):63-68. PubMed ID: 30857514
[TBL] [Abstract][Full Text] [Related]
17. Empiric aztreonam is associated with increased mortality compared to beta-lactams in septic shock.
Jaffa RK; Hammer J; Medaris LA; Anderson WE; Heffner AC; Pillinger KE
Am J Emerg Med; 2021 Oct; 48():255-260. PubMed ID: 34004470
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients.
Schoenenberger-Arnaiz JA; Ahmad-Diaz F; Miralbes-Torner M; Aragones-Eroles A; Cano-Marron M; Palomar-Martinez M
Eur J Hosp Pharm; 2020 Mar; 27(e1):e30-e35. PubMed ID: 32296502
[TBL] [Abstract][Full Text] [Related]
19. Can changes in renal function predict variations in β-lactam concentrations in septic patients?
Casu GS; Hites M; Jacobs F; Cotton F; Wolff F; Beumier M; De Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2013 Nov; 42(5):422-8. PubMed ID: 23993066
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
Delattre IK; Musuamba FT; Jacqmin P; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq P
Clin Biochem; 2012 Jul; 45(10-11):780-6. PubMed ID: 22503878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
